InvestorsHub Logo
Followers 43
Posts 5450
Boards Moderated 0
Alias Born 11/15/2013

Re: None

Tuesday, 10/04/2022 12:21:51 PM

Tuesday, October 04, 2022 12:21:51 PM

Post# of 403131
Found this by another poster to be quite interesting- Merck owns 2 of the 3 antifungal treatments mentioned in today’s PR (Pfizer owns the other one). One of Merck’s antifungal treatments they specifically mention, (CAS), alone only clears infection up to 50% but when combined with BRI clears almost 95% of the infection ?????? As quoted from the PR, “We look forward to broadening our planned studies of Brilacidin’s antifungal properties.” [That is a quote from one of the researchers, not IPIX.] Key word, PLANNED! The same antifungal treatment (CAS) is also the only one they specifically mention 2021 sales

Freedom is not free.

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent IPIX News